This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here
TheStreet Open House

10 Large-Cap Stocks With Upside

Stock quotes in this article: GOOG, AAPL, VALE, JPM, E, ITUB, TEVA

NEW YORK ( TheStreet) -- Teva Pharmaceutical (TEVA), Itau Unibanco Holding (ITUB), Eni (E), JPMorgan Chase (JPM), VALE (VALE), Apple (AAPL), Google (GOOG), Petroleo Brasileiro (PBR), Rio Tinto (RIO) and Bank of America (BAC) have upside potential of up to 56%, based on analysts' consensus estimates of 12-month price targets.

We have identified 10 stocks across diverse sectors such as banking, mining, oil and gas, pharma, consumer electronics and technology, which investors can consider for long-term growth. The selected stocks have a minimum market capitalization of $44 billion, and analysts expect these stocks to outperform their peers and the broader markets, based on their respective 12-month price targets. These stocks could generate 40% returns during 2011, according to analysts' consensus estimates with a high mean buy rating of 80%.


10. Teva Pharmaceutical (TEVA) is an Israel-based pharmaceutical company engaged in the development, manufacture, and marketing of generic drugs, specialty pharmaceuticals and active pharmaceutical ingredients. The company is the largest generic drug maker in the world with a global product portfolio of more than 1,250 molecules focused on neurological, respiratory and women's health therapeutics as well as biologics.

Net revenue reported for 2011 first quarter was $4.1 billion, growing 12% from the corresponding period in 2010. Net income earned during the quarter was $936 million, up 13% compared to the first quarter of 2010. Gross profit margin during 2010 fourth quarter was 58.8%, improving 40 basis points from the year-ago quarter.

Teva's performance during the first quarter saw increased contributions from its European business, and along with its high-growth generics markets in Eastern Europe, Latin America and Asia delivered double-digit growth during the quarter.

Revenue guidance for fiscal 2011 stood at $18.5 to $19 billion with EPS ranging from $4.9 to $5.2. Analysts expect the stock to deliver 29% return over the next one year with 81% analyst buy ratings. The stock is trading at 9.3 times its estimated 2011 earnings.

1 of 10

Select the service that is right for you!

COMPARE ALL SERVICES
Action Alerts PLUS
Try it NOW

Jim Cramer and Stephanie Link actively manage a real portfolio and reveal their money management tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
  • Weekly roundups
TheStreet Quant Ratings
Try it NOW
Only $49.95/yr

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
  • Upgrade/downgrade alerts
Stocks Under $10
Try it NOW

David Peltier, uncovers low dollar stocks with extraordinary upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
  • Weekly roundups
Dividend Stock Advisor
Try it NOW

Jim Cramer's protege, David Peltier, identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Alerts when market news affect the portfolio
  • Bi-weekly updates with exact steps to take - BUY, HOLD, SELL
Real Money Pro
Try it NOW

All of Real Money, plus 15 more of Wall Street's sharpest minds delivering actionable trading ideas, a comprehensive look at the market, and fundamental and technical analysis.

Product Features:
  • Real Money + Doug Kass Plus 15 more Wall Street Pros
  • Intraday commentary & news
  • Ultra-actionable trading ideas
Options Profits
Try it NOW

Our options trading pros provide daily market commentary and over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • 100+ monthly options trading ideas
  • Actionable options commentary & news
  • Real-time trading community
  • Options TV
To begin commenting right away, you can log in below using your Disqus, Facebook, Twitter, OpenID or Yahoo login credentials. Alternatively, you can post a comment as a "guest" just by entering an email address. Your use of the commenting tool is subject to multiple terms of service/use and privacy policies - see here for more details.
Submit an article to us!
DOW 17,042.90 -28.32 -0.17%
S&P 500 1,972.29 -5.51 -0.28%
NASDAQ 4,493.39 -12.4620 -0.28%

Brokerage Partners

Rates from Bankrate.com

  • Mortgage
  • Credit Cards
  • Auto

Free Newsletters from TheStreet

My Subscriptions:

After the Bell

Before the Bell

Booyah! Newsletter

Midday Bell

TheStreet Top 10 Stories

Winners & Losers

Register for Newsletters
Top Rated Stocks Top Rated Funds Top Rated ETFs